Eribulin, CAS 253128-41-5

Product Description: Eribulin (E7389) is a microtubule targeting agent that is used for the research of metastatic breast cancer. Eribulin inhibits the proliferation of cancer cells by binding microtubule proteins and microtubules.

Applications: Cancer-programmed cell death

Formula: C40H59NO11

References: [1]Okouneva, T., et al., Inhibition of centromere dynamics by eribulin (E7389) during mitotic metaphase. Mol Cancer Ther, 2008. 7(7): p. 2003-11./[2]Smith, J.A., et al., Eribulin binds at microtubule ends to a single site on tubulin to suppress dynamic instability. Biochemistry, 2010. 49(6): p. 1331-7./[3]Towle, M.J., et al., Eribulin induces irreversible mitotic blockade: implications of cell-based pharmacodynamics for in vivo efficacy under intermittent dosing conditions. Cancer Res, 2011. 71(2): p. 496-505./[4]Watanabe K, et, al. Low-dose eribulin reduces lung metastasis of osteosarcoma in vitro and in vivo. Oncotarget. 2019 Jan 4; 10(2): 161-174.

CAS Number: 253128-41-5

Molecular Weight: 729.90

Compound Purity: 99.92

Research Area: Cancer

Solubility: DMSO : 200 mg/mL (ultrasonic)

Target: ADC Cytotoxin;Apoptosis;Microtubule/Tubulin

• Artikelnummer: MEXHY-13442-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-13442-1
• Green Labware: Nein
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK